Taysha Gene Therapies, Inc.
TSHA
$2.31
-$0.07-2.94%
NASDAQ
| 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | -5.96% | -3.41% | -4.01% | 283.17% | 95.47% |
| Total Receivables | -- | -- | -- | -- | -- |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 45.66% | 24.41% | 8.16% | -70.88% | -52.24% |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -60.56% | -64.15% | -65.57% | -16.58% | -12.84% |
| Total Current Assets | -7.57% | -5.16% | -5.97% | 229.80% | 80.49% |
|
|
|||||
| Total Current Assets | -7.57% | -5.16% | -5.97% | 229.80% | 80.49% |
| Net Property, Plant & Equipment | -23.22% | -22.26% | -22.50% | -20.43% | -21.12% |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | -4.73% | -3.54% | -19.38% | -17.07% | -37.90% |
| Total Assets | -9.57% | -7.16% | -7.94% | 145.75% | 50.59% |
|
|
|||||
| Total Accounts Payable | -58.32% | -43.58% | -34.41% | -19.02% | 15.31% |
| Total Accrued Expenses | -24.12% | 1.34% | -17.39% | -48.72% | -26.72% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 6.60% | 14.03% | 18.01% | 7.08% | -3.20% |
| Total Finance Division Other Current Liabilities | -47.06% | -42.07% | -91.76% | -29.38% | -45.14% |
| Total Other Current Liabilities | -47.06% | -42.07% | -91.76% | -29.38% | -45.14% |
| Total Current Liabilities | -41.62% | -28.65% | -83.74% | -32.51% | -29.05% |
|
|
|||||
| Total Current Liabilities | -41.62% | -28.65% | -83.74% | -32.51% | -29.05% |
| Long-Term Debt | 4.79% | 8.48% | 11.47% | -1.35% | 6.16% |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -9.42% | -6.40% | -8.54% | -8.50% | -8.42% |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | 11.99% | -41.03% | -85.17% | -91.31% | -72.42% |
| Total Liabilities | -15.98% | -9.16% | -62.67% | -22.87% | -14.93% |
|
|
|||||
| Common Stock & APIC | 15.23% | 15.29% | 31.86% | 63.44% | 46.29% |
| Retained Earnings | -16.16% | -17.41% | -4.06% | -25.77% | -28.16% |
| Treasury Stock & Other | -810.76% | -- | -- | -- | -- |
| Total Common Equity | 2.25% | -4.55% | 280.80% | 393.33% | 460.24% |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | 2.25% | -4.55% | 280.80% | 393.33% | 460.24% |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 2.25% | -4.55% | 280.80% | 393.33% | 460.24% |
|
|
|||||